Skip to content
sugarisadrug.com
  • Home
  • Diabetes
  • Health News
  • General Sugar
  • Food Choices
  • Insulin
  • Mental Health
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Fructose
  • Sugar Science

Month: June 2026

1395-P: Effect of the Dual GLP-1/GIP Receptor Agonist Tirzepatide on Circulating Proteins Associated with ESKD Risk in Patients with Type 2 Diabetes

June 17, 2026 by sugaradmin

Introduction and Objective: In the SURPASS-4 clinical trial in patients with type 2 diabetes (T2D) at high cardiovascular risk, once-weekly treatment with the dual GLP-1/GIP receptor agonist, tirzepatide (TZP) resulted in substantial weight reduction, slower kidney function decline, and reduced albuminuria compared to insulin glargine. This post-hoc analysis evaluated the effect of TZP on 52-week […]

Read More
DiabetesLeave a Comment on 1395-P: Effect of the Dual GLP-1/GIP Receptor Agonist Tirzepatide on Circulating Proteins Associated with ESKD Risk in Patients with Type 2 Diabetes

2482-P: Metabolic Obesity Phenotypes and Advanced Liver Fibrosis: A Cross-Sectional Transient Elastography Study

June 17, 2026 by sugaradmin

Introduction and Objective: Body mass index (BMI) alone may miss obesity risk; ICMR-INDIAB study supports metabolic phenotyping into four groups based on their metabolic and BMI status: metabolically healthy non-obese (MHNO), metabolically obese non-obese (MONO), metabolically obese obese (MOO), and metabolically healthy obese (MHO). We assessed phenotype distribution and association with liver fibrosis stage using […]

Read More
DiabetesLeave a Comment on 2482-P: Metabolic Obesity Phenotypes and Advanced Liver Fibrosis: A Cross-Sectional Transient Elastography Study

2929-LB: Implementing a FibroScan Clinic in Primary Care: A Pilot Program

June 17, 2026 by sugaradmin

Introduction and Objective: The rates of screening for metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) with fibrosis-4 (FIB-4) index is slowly increasing in the primary care setting. Access to Vibration-Controlled Transient Elastography (FibroScan) remains a barrier in identifying high-risk MASLD and is currently underutilized. We evaluate an approach to implementation of […]

Read More
DiabetesLeave a Comment on 2929-LB: Implementing a FibroScan Clinic in Primary Care: A Pilot Program

1862-P: Medicaid Beneficiaries with Type 1 and Type 2 Diabetes Achieve ADA-Recommended Glycemic Targets Using the MiniMed 780G System

June 17, 2026 by sugaradmin

Introduction and Objective: People with diabetes (PWD) who are beneficiaries of Medicaid have worse glycemic outcomes than those with private insurance and are at increased risk for poor clinical outcomes. Barriers to accessing automated insulin delivery (AID) systems include age, complex/extensive prior authorization policies, unclear documentation requirements, and healthcare provider implicit bias about who is […]

Read More
DiabetesLeave a Comment on 1862-P: Medicaid Beneficiaries with Type 1 and Type 2 Diabetes Achieve ADA-Recommended Glycemic Targets Using the MiniMed 780G System

2784-LB: Real-World Weight Loss Outcomes among Adults with Type 2 Diabetes Using an AI-Enabled Weight Management Mobile App

June 17, 2026 by sugaradmin

Introduction and Objective: Mobile app-based weight management programmes using artificial intelligence (AI) coaching are increasingly used to support lifestyle change in people with type 2 diabetes (T2D), but real-world outcomes remain limited. The aim of this study was to evaluate weight loss among adults with T2D using an AI-enabled weight management app, and to examine […]

Read More
DiabetesLeave a Comment on 2784-LB: Real-World Weight Loss Outcomes among Adults with Type 2 Diabetes Using an AI-Enabled Weight Management Mobile App

2471-P: The Effect of Glucagon on Hepatic Insulin Extraction in Obesity with or without Hepatic Steatosis

June 17, 2026 by sugaradmin

Introduction and Objective: Insulin is secreted into the portal vein in response to nutrient ingestion. However, a significant proportion is extracted as it traverses the liver prior to reaching the systemic circulation. The effect of glucagon on hepatic extraction is uncertain. This is particularly germane to situations where postprandial suppression of glucagon is impaired, theoretically […]

Read More
DiabetesLeave a Comment on 2471-P: The Effect of Glucagon on Hepatic Insulin Extraction in Obesity with or without Hepatic Steatosis

2146-P: Gestational Blood Pressure Levels and Risk of Gestational and New-Onset Postpartum Diabetes

June 16, 2026 by sugaradmin

Introduction and Objective: Gestational diabetes (GDM) and hypertensive disorders of pregnancy often co-occur and are the leading causes of maternal morbidity. We aimed to examine whether the risks of GDM and new-onset postpartum diabetes (PPDM) increase across gestational blood pressure (BP) categories following the current guidelines with lower thresholds for hypertension (systolic/diastolic BP ≥130/80 mmHg) […]

Read More
DiabetesLeave a Comment on 2146-P: Gestational Blood Pressure Levels and Risk of Gestational and New-Onset Postpartum Diabetes

2466-P: Impact of Body Mass Index and Gender on Fractional Insulin Clearance in Healthy Individuals

June 16, 2026 by sugaradmin

Introduction and Objective: The reduction of the insulin Fractional Clearance Rate (FCR) is an early marker of insulin resistance and/or beta-cell disfunction that may be observed before prediabetes arises. Here we aim to investigate whether such reduction is associated with easily measurable anthropometric characteristics, like body mass index (BMI), age and gender.Methods: We studied 204 […]

Read More
DiabetesLeave a Comment on 2466-P: Impact of Body Mass Index and Gender on Fractional Insulin Clearance in Healthy Individuals

2210-P: Prototype Tool to Estimate the Probability of Type 1 Diabetes in Adults with New-Onset Diabetes across Four World Regions

June 16, 2026 by sugaradmin

Introduction and Objective: Type 1 diabetes in adults is frequently misclassified as type 2, delaying appropriate insulin treatment and leading to worse outcomes. We developed a probability-based tool that combines pre-laboratory clinical characteristics and laboratory results to estimate the likelihood of type 1 vs. type 2 diabetes among adults with new-onset diabetes across four geographic […]

Read More
DiabetesLeave a Comment on 2210-P: Prototype Tool to Estimate the Probability of Type 1 Diabetes in Adults with New-Onset Diabetes across Four World Regions

1601-P: Religious and Spiritual Coping among Latinx Parents of Youth with New-Onset Diabetes

June 16, 2026 by sugaradmin

Introduction and Objective: There is a need for interventions that respond to cultural strengths and psychosocial burdens of underserved youth with diabetes and their families. Religion/spirituality is a resource that Latinx youth and their parents may use when other resources are unavailable. There is a gap in knowledge about the religious/spiritual experiences and needs of […]

Read More
DiabetesLeave a Comment on 1601-P: Religious and Spiritual Coping among Latinx Parents of Youth with New-Onset Diabetes

Posts navigation

Older posts
Newer posts

Recent Posts

  • 2955-LB: Gestational Glucose Intolerance and Future Cardiovascular Disease Risk
  • 1779-P: Significant Synergistic Hypoglycemic Effects in Type 2 Diabetes Mellitus by HDM1010
  • 2954-LB: The Triglyceride Response to the Rise in Estradiol in Obese Pregnancies: Implications for Fetal Overgrowth
  • Is Zepbound or Wegovy More Effective?
  • 1753-P: CGM-Based Metrics in Insulin-Naive Adults with T2D Receiving IcoSema vs. Glargine U100: Post Hoc Analysis of COMBINE 4.

Recent Comments

  • A WordPress Commenter on SUCROSE: “PURE” ENERGY AT A PRICE

Archives

  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • November 2024
  • October 2024
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • May 2017

Categories

  • Celebrity Health
  • Diabetes
  • Food Choices
  • Fructose
  • General Sugar
  • Glucose
  • Health News
  • Insulin
  • Mental Health
  • Natural Unrefined Sugar
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Sucrose
  • Sugar Science

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
  • Home
  • Diabetes
  • Health News
  • General Sugar
  • Food Choices
  • Insulin
  • Mental Health
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Fructose
  • Sugar Science

© 2026 Sugar is a DRUG | Sugar Addiction Awareness